438 related articles for article (PubMed ID: 19268893)
1. Anatomic and visual outcomes of noninfectious endophthalmitis after intravitreal triamcinolone.
Yoon SJ; Rhee DY; Marx JL; Blaha GR; Rogers AH; Baumal CR; Reichel E; Duker JS
Am J Ophthalmol; 2009 Jun; 147(6):1031-6. PubMed ID: 19268893
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal triamcinolone as adjunctive treatment to laser panretinal photocoagulation for concomitant proliferative diabetic retinopathy and clinically significant macular oedema.
Margolis R; Singh RP; Bhatnagar P; Kaiser PK
Acta Ophthalmol; 2008 Feb; 86(1):105-10. PubMed ID: 17608830
[TBL] [Abstract][Full Text] [Related]
3. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.
Ozdek S; Bahçeci UA; Gürelik G; Hasanreisoğlu B
J Diabetes Complications; 2006; 20(4):246-51. PubMed ID: 16798476
[TBL] [Abstract][Full Text] [Related]
4. The transient efficacy of a single intravitreal triamcinolone acetonide injection for diabetic macular edema.
Desatnik H; Habot-Wilner Z; Alhalel A; Moroz I; Glovinsky J; Moisseiev J
Isr Med Assoc J; 2006 Jun; 8(6):383-7. PubMed ID: 16833165
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes.
Lam DS; Chan CK; Mohamed S; Lai TY; Lee VY; Liu DT; Li KK; Li PS; Shanmugam MP
Ophthalmology; 2007 Dec; 114(12):2162-7. PubMed ID: 17459479
[TBL] [Abstract][Full Text] [Related]
6. Outcome of intravitreal triamcinolone acetonide in postoperative cystoid macular oedema.
Konstantopoulos A; Williams CP; Luff AJ
Eye (Lond); 2008 Feb; 22(2):219-22. PubMed ID: 17016463
[TBL] [Abstract][Full Text] [Related]
7. Outcome of intravitreal triamcinolone in uveitis.
Kok H; Lau C; Maycock N; McCluskey P; Lightman S
Ophthalmology; 2005 Nov; 112(11):1916.e1-7. PubMed ID: 16171868
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal triamcinolone acetonide for treatment of cystoid macular oedema in patients with retinitis pigmentosa.
Ozdemir H; Karacorlu M; Karacorlu S
Acta Ophthalmol Scand; 2005 Apr; 83(2):248-51. PubMed ID: 15799743
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion.
Chen SD; Sundaram V; Lochhead J; Patel CK
Am J Ophthalmol; 2006 May; 141(5):876-883. PubMed ID: 16527226
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema.
Bae JH; Lee CS; Lee SC
Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170
[TBL] [Abstract][Full Text] [Related]
11. Optical coherence tomographic pattern may predict visual outcome after intravitreal triamcinolone for diabetic macular edema.
Gibran SK; Khan K; Jungkim S; Cleary PE
Ophthalmology; 2007 May; 114(5):890-4. PubMed ID: 17467527
[TBL] [Abstract][Full Text] [Related]
12. Steroid hypopyon following intravitreal triamcinolone acetonide injection in a pseudophakic patient.
Amato JE; Lee DH; Santos BA; Akduman L
Ocul Immunol Inflamm; 2005; 13(2-3):245-7. PubMed ID: 16019686
[TBL] [Abstract][Full Text] [Related]
13. Posterior juxtascleral infusion of modified triamcinolone acetonide formulation for refractory diabetic macular edema: one-year follow-up.
Veritti D; Lanzetta P; Perissin L; Bandello F
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2391-7. PubMed ID: 19117937
[TBL] [Abstract][Full Text] [Related]
14. Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonide.
Jonas JB; Kreissig I; Spandau UH; Harder B
Am J Ophthalmol; 2006 Mar; 141(3):579-80. PubMed ID: 16490517
[TBL] [Abstract][Full Text] [Related]
15. Posterior subtenon triamcinolone, intravitreal triamcinolone and grid laser photocoagulation for the treatment of macular edema in branch retinal vein occlusion.
Ozdek S; Deren YT; Gurelik G; Hasanreisoglu B
Ophthalmic Res; 2008; 40(1):26-31. PubMed ID: 18025838
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema.
Androudi S; Letko E; Meniconi M; Papadaki T; Ahmed M; Foster CS
Ocul Immunol Inflamm; 2005; 13(2-3):205-12. PubMed ID: 16019680
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of intravitreal triamcinolone acetonide in long standing diabetic macular edema: a microperimetry and optical coherence tomography study.
Grenga P; Lupo S; Domanico D; Vingolo EM
Retina; 2008 Oct; 28(9):1270-5. PubMed ID: 18664938
[TBL] [Abstract][Full Text] [Related]
18. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
Roth DB; Scott IU; Gloth JM; Green SN; Yarian DL; Wheatley M
Retina; 2007; 27(9):1201-4. PubMed ID: 18046225
[TBL] [Abstract][Full Text] [Related]
19. Effects of repeated injection of intravitreal triamcinolone on macular oedema in central retinal vein occlusion.
Wang L; Song H
Acta Ophthalmol; 2009 May; 87(3):285-9. PubMed ID: 18507724
[TBL] [Abstract][Full Text] [Related]
20. One year of intravitreal injections of steroids.
Deckers V; Priem H; Verbraeken H
Bull Soc Belge Ophtalmol; 2005; (297):69-77. PubMed ID: 16281735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
